Max Healthcare Institute Limited (MAXHEALTH) — Board Meeting | 14 November 2025

· NSE 🟡 Notable ✨ Positive
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Max Healthcare's board approved Q2 FY2025-26 consolidated results showing revenue of ₹2,135.47 crores and net profit of ₹491.30 crores. H1 FY26 consolidated net profit reached ₹799.27 crores on revenue of ₹4,163.04 crores. The company generated ₹817.59 crores operating cash flow in H1 while investing ₹858.90 crores capex. Subsidiaries CRL and JHL merger completed post-NCLT approval (November 7), and 2,00,580 stock options were granted at ₹900/share. Dividend of ₹1.5 per share was paid.

📄 View Original Announcement (PDF)

About Max Healthcare Institute Limited (MAXHEALTH)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,02,200.33 Cr P/E: 101.2

View full MAXHEALTH stock details →

📡 Get AI alerts when MAXHEALTH files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MAXHEALTH — Free

📊 More MAXHEALTH filings

See all MAXHEALTH filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MAXHEALTH files new disclosures

Track MAXHEALTH filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MAXHEALTH — Free

Free account · 2 AI queries/day